{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:48:56Z","timestamp":1774788536063,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>During the vaccination campaigns, puppies younger than 3 months old are not targeted and remain unvaccinated for at least the first year of their lives. Almost half of the reported rabid dogs are 6 months or younger. Hence, we should recommend the vaccination against rabies of young puppies. Unfortunately, owing to the exposure of puppies to infections with either canine parvovirus (CPV) or distemper virus (CDV) after the intervention of the vaccinators, owners are reluctant to vaccinate puppies against rabies. Therefore, it is necessary to include the CPV and CDV valences in the vaccine against rabies. Multivalent DNA-based vaccination in dogs, including rabies and distemper valences, could help in raising vaccine coverage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We have designed monovalent and multivalent DNA-based vaccine candidates for <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> assays. These plasmids encode to the rabies virus glycoprotein and\/or the canine distemper virus hemagglutinin. The first strategy of multivalent DNA-based vaccination is by mixing plasmids encoding to a single antigen each. The second is by simply fusing the genes of the antigens together. The third is by adding the foot and mouth disease virus (FMDV) 2A oligopeptide gene into the antigen genes. The last strategy is by the design and use of a bicistronic plasmid with an \u201cInternal Ribosome Entry Site\u201d (IRES) domain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The monovalent construct against canine distemper was efficiently validated by inducing higher humoral immune responses compared to cell-culture-derived vaccine both in mice and dogs. All multivalent plasmids efficiently expressed both valences after <jats:italic>in vitro<\/jats:italic> transfection of BHK-21 cells. In BALB\/c mice, the bicistronic IRES-dependant construct was the most efficient inducer of virus-neutralizing antibodies against both valences. It was able to induce better humoral immune responses compared to the administration of either cell-culture-derived vaccines or monovalent plasmids. The FMDV 2A was also efficient in the design of multivalent plasmids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In a single shot, the design of efficient multivalent plasmids will be very beneficial for DNA-based vaccination against numerous diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-9-319","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T15:14:12Z","timestamp":1356621252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Design of different strategies of multivalent DNA-based vaccination against rabies and canine distemper in mice and dogs"],"prefix":"10.1186","volume":"9","author":[{"given":"Leila","family":"Touihri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami Belhaj","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yacine","family":"Chtourou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahma","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chokri","family":"Bahloul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,27]]},"reference":[{"key":"1976_CR1","first-page":"360","volume":"83","author":"DL Knobel","year":"2005","unstructured":"Knobel DL, Cleaveland S, Coleman PG, F\u00e8vre EM, Meltzer MI, Miranda ME, Shaw A, Zinsstag J, Meslin FX: Re-evaluating the burden of rabies in Africa and Asia bull. World Health Organ 2005, 83: 360-368.","journal-title":"World Health Organ"},{"key":"1976_CR2","volume-title":"Outcomes of a consultative meeting. Held on 10","author":"WHO","year":"2007","unstructured":"WHO: Outcomes of a consultative meeting. Held on 10 January 2007: rabies and envenomings: a neglected public health issue. http:\/\/www.who.int\/bloodproducts\/animal_sera\/Rabies.pdf"},{"key":"1976_CR3","first-page":"931","volume-title":"Report from WHO expert consultation on rabies","author":"WHO","year":"2004","unstructured":"WHO: Report from WHO expert consultation on rabies. WHO, technical report series, Geneva, Switzerland; 2004:931. http:\/\/www.who.int\/rabies\/trs931_%2006_05.pdf"},{"issue":"Suppl 4","key":"1976_CR4","doi-asserted-by":"publisher","first-page":"S693","DOI":"10.1093\/clinids\/10.Supplement_4.S693","volume":"10","author":"AJ Belotto","year":"1988","unstructured":"Belotto AJ: Organization of mass vaccination for dog rabies in brazil. Rev Infect Dis 1988,10(Suppl 4):S693-S696.","journal-title":"Rev Infect Dis"},{"issue":"Suppl 4","key":"1976_CR5","doi-asserted-by":"publisher","first-page":"S697","DOI":"10.1093\/clinids\/10.Supplement_4.S697","volume":"10","author":"B Chomel","year":"1988","unstructured":"Chomel B, Chappuis G, Bullon F, Cardenas E, de Beublain TD, Lombard M, Giambruno E: Mass vaccination campaign against rabies: are dogs correctly protected? the Peruvian experience. Rev Infect Dis 1988,10(Suppl 4):S697-S702.","journal-title":"Rev Infect Dis"},{"issue":"Suppl 4)","key":"1976_CR6","doi-asserted-by":"publisher","first-page":"S703","DOI":"10.1093\/clinids\/10.Supplement_4.S703","volume":"10","author":"F Ben Osman","year":"1988","unstructured":"Ben Osman F, Haddad N: Experience in field rabies control programs. Rev Infect Dis 1988,10(Suppl 4)):S703-S706.","journal-title":"Rev Infect Dis"},{"key":"1976_CR7","first-page":"15","volume":"65","author":"A Chadli","year":"1988","unstructured":"Chadli A: Rabies in Tunisia a comparative study of results from the last 36 years. Archs Inst Pasteur Tunis 1988, 65: 15-27.","journal-title":"Archs Inst Pasteur Tunis"},{"key":"1976_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1017\/S0950268897008601","volume":"120","author":"C Mitmoonpitak","year":"1998","unstructured":"Mitmoonpitak C, Tepsumethanon V, Wilde H: Rabies in Thailand. Epidemiol Infect 1998, 120: 165-169. 10.1017\/S0950268897008601","journal-title":"Epidemiol Infect"},{"key":"1976_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1863-2378.2009.01306.x","volume":"58","author":"L Touihri","year":"2011","unstructured":"Touihri L, Zaouia I, Elhili K, Dellagi K, Bahloul C: Evaluation of mass vaccination campaign coverage against rabies in dogs in Tunisia. Zoonoses Public Health 2011, 58: 110-118. 10.1111\/j.1863-2378.2009.01306.x","journal-title":"Zoonoses Public Health"},{"key":"1976_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11259-008-9040-3","volume":"32","author":"K Dhama","year":"2008","unstructured":"Dhama K, Mahendran M, Gupta PK, Rai A: DNA vaccines and their applications in veterinary practice: current perspectives. Vet Res Commun 2008, 32: 341-356. 10.1007\/s11259-008-9040-3","journal-title":"Vet Res Commun"},{"key":"1976_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrg2432","volume":"9","author":"MA Kutzler","year":"2008","unstructured":"Kutzler MA, Weiner DB: DNA vaccines: ready for prime time? Nat Rev Genet 2008, 9: 776-788. 10.1038\/nrg2432","journal-title":"Nat Rev Genet"},{"key":"1976_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0264-410X(03)00568-1","volume":"22","author":"C Bahloul","year":"2003","unstructured":"Bahloul C, Ben Hadj Ahmed S, B\u2019chir BI, Kharmachi H, Hayouni E, Dellagi K: Post-exposure therapy in mice against experimental rabies: a single injection of DNA vaccine is as effective as five injections of cell culture-derived vaccine. Vaccine 2003, 22: 177-184. 10.1016\/S0264-410X(03)00568-1","journal-title":"Vaccine"},{"key":"1976_CR13","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.vaccine.2005.09.016","volume":"24","author":"C Bahloul","year":"2006","unstructured":"Bahloul C, Taieb D, Diouani MF, Ben Hadj Ahmed S, Chtourou Y, B\u2019chir BI, Kharmachi H, Dellagi K: Field trials of a very potent rabies DNA vaccine which induced long lasting virus-neutralizing antibodies and protection in dogs in experimental conditions. Vaccine 2006, 24: 1063-1072. 10.1016\/j.vaccine.2005.09.016","journal-title":"Vaccine"},{"key":"1976_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/334320a0","volume":"334","author":"J Pelletier","year":"1988","unstructured":"Pelletier J, Sonenberg N: Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 1988, 334: 320-325. 10.1038\/334320a0","journal-title":"Nature"},{"key":"1976_CR15","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/jvi.62.8.2636-2643.1988","volume":"62","author":"SK Jang","year":"1988","unstructured":"Jang SK, Kr\u00e4usslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E: A: segment of the 5\u2032 nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 1988, 62: 2636-2643.","journal-title":"J Virol"},{"key":"1976_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bbagrm.2009.07.005","volume":"1789","author":"L Balvay","year":"2009","unstructured":"Balvay L, Soto Rifo R, Ricci EP, Decimo D, Ohlmann T: Structural and functional diversity of viral IRESes. Biochim Biophys Acta 2009, 1789: 542-557. 10.1016\/j.bbagrm.2009.07.005","journal-title":"Biochim Biophys Acta"},{"key":"1976_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/353090a0","volume":"353","author":"DG Macejak","year":"1991","unstructured":"Macejak DG, Sarnow P: Internal initiation of translation mediated by the 5\u2032 leader of a cellular mRNA. Nature 1991, 353: 90-94.","journal-title":"Nature"},{"key":"1976_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/hum.1998.9.3-287","volume":"9","author":"Y Zhou","year":"1998","unstructured":"Zhou Y, Aran J, Gottesman MM, Pastan I: Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vector. Hum Gene Ther 1998, 9: 287-293. 10.1089\/hum.1998.9.3-287","journal-title":"Hum Gene Ther"},{"key":"1976_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1006\/mthe.2000.0050","volume":"1","author":"H Mizuguchi","year":"2000","unstructured":"Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T: IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 2000, 1: 376-382. 10.1006\/mthe.2000.0050","journal-title":"Mol Ther"},{"key":"1976_CR20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/jvi.54.3.651-660.1985","volume":"54","author":"BH Robertson","year":"1985","unstructured":"Robertson BH, Grubman MJ, Weddell GN, Moore DM, Welsh JD, Fischer T, Dowbenko DJ, Yansura DG, Small B, Kleid DG: Nucleotide and amino acid sequence coding for polypeptides of foot and mouth disease virus type A12. J Virol 1985, 54: 651-660.","journal-title":"J Virol"},{"key":"1976_CR21","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1099\/0022-1317-82-5-1027","volume":"82","author":"ML Donnelly","year":"2001","unstructured":"Donnelly ML, Hughes LE, Luke G, Mendoza H, ten Dam E, Gani D, Ryan MD: The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol 2001, 82: 1027-1041.","journal-title":"J Gen Virol"},{"key":"1976_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1398-9219.2004.00205.x","volume":"5","author":"P De Fellipe","year":"2004","unstructured":"De Fellipe P, Rayan MD: Targeting of proteins derived from self processing polyproteins containing multiple signal sequences. Traffic 2004, 5: 616-626. 10.1111\/j.1398-9219.2004.00205.x","journal-title":"Traffic"},{"key":"1976_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0092-1157(79)80038-4","volume":"7","author":"EA Fitzgerald","year":"1979","unstructured":"Fitzgerald EA, Cabasso VJ, Smith JS, Rastogi SC: A collaborative study on the testing of rabies immune globulin (human) by the mouse neutralization test (MNT) and the rapid fluorescent focus inhibition test (RFFIT). J Biol Stand 1979, 7: 67-72. 10.1016\/S0092-1157(79)80038-4","journal-title":"J Biol Stand"},{"key":"1976_CR24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4269\/ajtmh.1999.61.879","volume":"61","author":"C Seghaier","year":"1999","unstructured":"Seghaier C, Cliquet F, Hammami S, Aouina T, Tlatli A, Aubert M: Rabies mass vaccination campaigns in Tunisia: are vaccinated dogs correctly immunized? AmJTrop Med Hyg 1999, 61: 879-884.","journal-title":"AmJTrop Med Hyg"},{"key":"1976_CR25","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1086\/314977","volume":"180","author":"S Bavari","year":"1999","unstructured":"Bavari S, Ulrich RG, LeClaire RD: Cross-reactive antibodies prevent the lethal effects of staphylococcus aureus superantigens. J Infect Dis 1999, 180: 1365-1369. 10.1086\/314977","journal-title":"J Infect Dis"},{"key":"1976_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4161\/hv.4.1.4876","volume":"4","author":"RP Braun","year":"2008","unstructured":"Braun RP, Dong L, Jerome S, Herber R, Roberts LK, Payne LG: Multi-antigenic DNA immunization using herpes simplex virus type 2 genomic fragments. Hum Vaccines 2008, 4: 36-43. 10.4161\/hv.4.1.4876","journal-title":"Hum Vaccines"},{"key":"1976_CR27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1128\/JVI.01846-09","volume":"84","author":"G Arrode-Brus\u00e9s","year":"2010","unstructured":"Arrode-Brus\u00e9s G, Sheffer D, Hegde R, Dhillon S, Liu Z, Villinger F, Narayan O, Chebloune Y: Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccine. J Virol 2010, 84: 1243-1253. 10.1128\/JVI.01846-09","journal-title":"J Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-9-319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:26:34Z","timestamp":1630531594000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-9-319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1976"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-9-319","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"31 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"319"}}